Poison gas tested as lifesaver for critically ill patients
NCT ID NCT04870125
Summary
This early-stage study is testing whether inhaling very low doses of carbon monoxide (CO) is safe and can help treat severe lung inflammation caused by sepsis or pneumonia. The gas is being given to a small number of critically ill patients who are on breathing machines. Researchers want to see if a precise dosing method can safely deliver the gas and if it reduces inflammation and improves organ function.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
-
Duke University Hospital
Durham, North Carolina, 27710, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
New York-Presbyterian Brooklyn Methodist Hospital
Brooklyn, New York, 11215, United States
-
Washington University
St Louis, Missouri, 63110, United States
-
Weill Cornell Medical College
New York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.